Congestive heart failure (CHF) currently affects about 5 million Americans. It is in-a-nutshell a “pump failure” medical issue that can have many causes. Traditional medical management includes diet to drop excess pounds and help reduce high blood pressure, medications that support the heart and ease the strain on it, exercise, sodium restriction, and supplemental oxygen or surgery including implantation of a pacemaker or other heart function assist devices if needed.
The question arises, “Is there anything available for CHF that is less invasive or fraught with side or adverse effects than is true of many mainstream treatments? There is. Among these: One very powerful treatment modality is external counterpulsation (EECP), an FDA approved computer-driven machine that some doctors refer to as “a nonsurgical bypass.” In-a-word, it mechanically and effortlessly increases blood flow to organs and tissues including the heart, and also facilitates the growth of new blood vessels. In a randomized study published in the Journal of the American College of Cardiology Vol. 48, No. 6, 2006 a team of scientists laid out findings that indicated that EECP increased exercise tolerant in participants with mild-to-moderate Congestive Heart Failure. Critics argued the study did not rule out the placebo effect.
But what takes place when EECP is used in tandem with other leading edge treatments such as high dose ubiquinone (Coenzyme Q10) and infusions of stem cell rich bone marrow? Perhaps a great deal. This, at least, is what CHF patients treated using these and other therapeutic agents by Dr. Steenblock have reported.
If you or someone you know has Congestive Heart Failure and are looking for promising forms of intervention such as EECP, do not hesitate to call Dr. Steenblock’s Clinic toll free at 1-800-1063 and request more information. Or visit his website at StrokeDoctor.com and read what’s there and then call or e-mail the clinic using the online contact form under “Contact Us.”